People who are subjected to both hot weather and air pollution caused by fires at the same time are at higher risk of dying ...

Tirzepatide (Mounjaro; Lilly) appears to reduce major cardiovascular events beyond what can be achieved with placebo for ...

A more comprehensive view of bleeding burden can help inform discussions between patients and doctors, a researcher says.

One year after the FDA's approval, Shmuel Chen and Philippe Généreux give an update on the successes and challenges in this ...

Delivery of preventive cardiovascular care seems to improve for patients covered by Medicaid when accountable care ...

Enrollment by Minneapolis Heart Institute Foundation at Abbott Northwestern Hospital marks a significant milestone in the ...

Pavel Osmancik and C. Michael Gibson discuss whether catheter ablation is superior to risk factor modification with ...

With an influential tenure in industry followed by a fruitful post-retirement, Woodall is remembered for his leadership and ...

Women were, however, more likely to experience bleeding and cardiac tamponade and less likely to get an ICD/CRT-D device.

This “actionable process” harnesses invasive coronary functional testing to enable tailored care, a TRI-NOCA investigator says.

The drug lowered free IL-6 and hs-CRP levels but didn’t affect outcomes, raising doubts about the inflammatory hypothesis.